Results for “”

Entry Author Date Location
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
FDA Clears Aerie’s Combo Glaucoma Drug, But Will it Sell? 03/13/19 New York
Drug-Price Watchdog ICER Dives into Trump-Fueled Pharma Rebate Debate 03/13/19 National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
Privacy Watch: FTC, Facebook, EU, the Cloud Act, & More CA bills 03/04/19 San Francisco
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future 03/01/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray 02/26/19 New York
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Cloud Tech Firm Nasuni Takes in $25M in Telstra-Led Funding Round 02/19/19 Boston
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More 02/15/19 National
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans 02/12/19 National
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
Privacy Watch: Facebook Rebounds, But Privacy Concerns Accelerate 02/04/19 San Francisco
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Equidate, Re-Named Forge Global, Boosts Series B to $85M 01/29/19 San Francisco
Norwest VC Eyes Waves of Change in A.I., Marketing, Cloud for 2019 01/28/19 San Francisco
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More 01/25/19 National
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter 01/16/19 National
A VC’s Take: Global Volatility Hurts U.S. Venture Ecosystem 01/15/19 San Francisco
Tech Companies Share Shutdown Losses, With Little Chance of Back Pay 01/11/19 San Francisco
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Uncertainty Grows for Biotech as Government, FDA Shutdown Drags On 01/10/19 National
FAANG, Public Trust, Valuations, in 2019: The Read from Menlo Ventures 01/10/19 San Francisco
Page 1 of 25 next page »